Pocket Pediatrics: The Massachusetts General Hospital for Children Handbook of Pediatrics (Pocket Notebook Series), 2 Ed.

ATOPIC DERMATITIS (AD)

Definition (J Allergy Clin Immunol 2006;118:152)

• Chronic, immune-mediated, inflammatory, pruritic skin dz occurring in pts w/ atopic diathesis, w/ variable clinical pattern depending on age

Pathophysiology (J Invest Dermatol 2012;132:949)

• Impaired epidermal barrier: Stratum corneum defects → ↓ epidermal water content

• Mutations in the filaggrin gene predispose to AD (filaggrin is a protein in the stratum corneum that helps maintain hydration and has anti-staph properties)

• Dry skin → pruritis and scratching → trauma and inflammation

• Water loss → changes in epidermal lipids → cracks in the stratum corneum

• Antigenic and irritant agents penetrate the skin and activate immune cells

• Immune dysfunction w/ exaggerated Th2 response: IgE prod, eosinophilia, and proinflammatory cytokines → hyperactive immune response → extravasation of inflammatory cells, cellular signaling at injury site

• Pruritus mechanism not just 2/2 histamine

• Triggers: Stress-induced immunomodulation, food + inhalant allergens, chemical irritants, skin infection, hot/humid or cold/dry weather, viral infections esp w/ fever

Epidemiology (N Engl J Med 2008;358:1483, N Engl J Med 2005;352:2314)

• Affects 15–30% of children and 2–10% of adults

• Age of onset: 45% in 1st 6 mo of life, 60% before age 1; 85% before age 5

• 70% of children have spontaneous remission before adolescence

• 77% concordance rate for monozygotic twins; 15% for dizygotic

• Asthma develops in approx 30% and allergic rhinitis in 35% of children with AD

Clinical Manifestations (J Allergy Clin Immunol 2006;118:152)

Infantile stage (infancy–2 yo)

• Location: Cheeks, forehead, scalp, may spread to trunk

• Intensely pruritic, erythematous, scaly lesions, may have vesicles or serous exudate in severe cases

Childhood stage (2 yo–puberty)

• Location: Flexural surfaces, wrists, ankles, hands, feet, neck, dorsum of extremities

• Less exudation; more lichenified papules and plaques

Adult stage (puberty+)

• Location: Flexural surfaces, face, neck, upper arms, back, hands, feet

• Dry, scaly erythematous papules & plaques; lichenified plaques in areas of chronicity

• W/ severe cases, any area involved, but axillary, groin, & gluteal areas usually spared

• Complications: Bacterial or viral superinfxn of eczematous sites (e.g., eczema herpeticum)

Diagnostic Studies (N Engl J Med 2005;352:2314)

• Clinical criteria: Evidence of itchy skin + 3 of the following:

• H/o involvement of skin creases

• H/o generally dry skin in the past year

• H/o asthma or hay fever (or FHx atopy in 1st-degree relative for pts <4 yo)

• Onset of sx at <2 yo (criterion not used if child <4 yo)

• Dermatitis of flex surfaces (or cheeks/forehead/outer aspects of ext for pts <4 yo)

• Specific allergy testing not routinely recommended, depends on dz severity

• Ddx: Psoriasis, contact dermatitis, seborrheic dermatitis, scabies, vit def, drug rxns

Management (Pediatrics 2008;122:812, Am Fam Physician 2007;75:523)

Eliminate exacerbating factors: Soap, hot water, abrasive materials (synthetics, wool), physiologic/emotional stress, individual-specific allergens and irritants

Skin hydration w/ emollients even when asymptomatic: Avoid lotions (worsen xerosis via water evap); use thick creams/ointments (hydrolated petrolatum, petroleum jelly) are most effective; apply immediately after bathing

Topical steroids: Limit to bid; only low potency on face, genital, intertriginous areas

• 1–2.5% hydrocortisone (low potency) for mild AD

• 0.1% triamcinolone (medium potency) for more severe AD

Topical calcineurin inhibitors (1% pimecrolimus & 0.03% tacrolimus): Approved as 2nd-line Rx in kids >2 yo who respond poorly or are intolerant to topical steroids

• Adverse effects: Burning sensation of skin and irritation; should use sun protection

• Benefits: Not assoc w/ skin atrophy, safe for use on face

• FDA “black box warning” safety not clear w/ long-term/continuous use & in pts <2 yo

Systemic tx used in severe cases: UV light, systemic immunosuppressants

Adjunctive tx: Sedating antihistamines for pruritis – due to sedative effect (non-sedating antihistamines not effective for itch), wet dressings, bleach baths to ↓ local skin infections



If you find an error or have any questions, please email us at admin@doctorlib.org. Thank you!